This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As we wrap up another year and get ready for 2025 to begin, it is once again time for everyone’s favorite annual tradition of Health IT Predictions! Check out the community’s predictions down below and be sure to follow along as we share more 2025 Health IT Predictions !
As we wrap up another year and get ready for 2025 to begin, it is once again time for everyone’s favorite annual tradition of Health IT Predictions! Check out the community’s predictions down below and be sure to follow along as we share more 2025 Health IT Predictions !
By simulating trials at scale, QuantHealth’s platform can lower risks, expedite, and optimize drugdevelopment. QuantHealth is already working with several global pharmaceutical companies to use its product in clinical trial design and development. Petra Jantzer, Ph.D., Originally announced January 8th, 2024
. “The antiquated CRO model is failing the industry and failing patients, with inefficiencies and misaligned incentives propelling costs and causing researchers to stumble before their breakthroughs can reach patients,” said Meri Beckwith , Co-Founder of Lindus Health.
As precision medicine becomes more nuanced and complex, biopharmaceutical companies are increasingly turning to AI to enhance the utility, performance, and scalability of computational pathology analyses for drugdevelopment and diagnostics. Aignostics is funded by leading investors and has operations in Berlin and New York.
Everyone from the board and the C-suite to the health IT team to doctors and nurses are talking about how digital technologies can change the industry and bring about better care and better outcomes. You predict that decentralization will become a major theme for health and lifescience organizations. Please elaborate.
In our interview, Gil emphasizes the critical role of AI in expediting the discovery of new drugs, citing the lengthy and costly nature of traditional drugdevelopment processes. However, with AI-driven approaches, Aion Labs is paving the way for a paradigm shift in drug discovery.
As we kick off 2024, we wanted to start the new year with a series of 2024 Health IT predictions. Given the improvements in costs, trial sponsors can now take advantage of these exchanges at scale and leverage the data for both pre-screening and health economic analysis.
This comes after Francisco Partners, a private equity firm, acquired the health analytics assets of IBM Watson Health in 2022 and rebranded the division as Merative. Merative's product portfolio will focus on six key areas: Health Insights: Providing actionable insights to improve healthcare delivery and decision-making.
The development and manufacturing process for these important new drugs is very different from traditional medicines. This article focuses on the technology that ensures quality in the process, and is based on a conversation with Graziella Piras, PhD, LifeScience Business Development Director at 908 Devices.
This strategic consolidation establishes PicnicHealth as the leading patient-centric evidence-generation partner within a rapidly evolving lifesciences landscape. By combining forces, we can unlock the potential of patient-centered studies and provide best-in-class solutions to support therapeutic development.”
Cofounded by Dr. Siddhartha Mukherjee and Reid Hoffman, Manas AI Leverages Proprietary AI, Generative Computational Chemistry, and Best-in-Class Biology to Cut DrugDevelopment Timelines and Costs, Transforming Cancer and Rare Disease Treatments Company Raises $24.6 ” Backed by Leading Investors Manas AI has raised $24.6
Deerfield invests across the lifescience, medical device, diagnostic, digital health, and health service industries at every stage of evolution. The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drugdevelopment in oncology.
Atropos Health offers the world’s first award-winning platform for faster data evaluation, evidence generation, and Generative AI innovation of research and care. This platform is designed to meet the demands of health systems and lifescience companies working to solve increasingly global, diverse, and data-intensive healthcare problems.
Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and lifesciences firms, and insurance companies serve patients as end users. She was the patient keynote speaker at DPHARM 2021 and is a HIMSS Digital Health Influencer. Connect with her at [link]. Did you enjoy this post?
We are particularly excited about the ability of these tools to drive more efficient and faster drugdevelopment processes in the biopharma industry.” “The About Novalis LifeSciences LLC Novalis LifeSciences is the investment arm of Novalis Capital Partners, a boutique investment and advisory firm for the LifeScience industry.
.” Prognos Health’s platform is used by over 70 lifesciences customers to accelerate the development of new drugs, improve the safety and efficacy of existing drugs, and identify new patient populations that may benefit from specific treatments.
Mountain Group Partners is an investor dedicated to investing in and actively guiding transformational businesses in the Technology, Animal Health, and LifeSciences sectors. Technology investments focus on business and healthcare technology, targeting those ideas with quantifiable development risk and a rapid path to market.
Cornerstone’s founders incubated the company in partnership with Initiate Studios, a new venture studio that co-creates companies at the intersection of healthcare, lifesciences and technology. Poor quality data leads to drugdevelopment being delayed, patients being misdiagnosed and inaccurate scientific conclusions.
Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! Subscribe Today!
As we head into 2023, we wanted to kick off the new year with a series of 2023 Health IT predictions. Jesse Cugliotta, Global Industry GTM Lead, Healthcare & LifeSciences at Snowflake. Can they see changes locally in the tumor microenvironment that indicate the drug is having a biology effect?
As we kick off 2024, we wanted to start the new year with a series of 2024 Health IT predictions. Greg Wujek, Global Health Industry Consultant at SAS Robots as providers comes of age. In fact, we got so many that we had to narrow them down to just the best and most interesting.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content